Publication:
An Open-Label Trial to Assess the Safety of Regorafenib in Turkish Patients with Metastatic Colorectal Cancer (mCRC) That Progressed on Standard Therapy (REGARD)

Research Projects

Organizational Units

Journal Issue

Abstract

…

Description

ESMO 17th World Congress on Gastrointestinal Cancer -- JUL 01-04, 2015 -- Barcelona, SPAIN

Keywords

Citation

WoS Q

Scopus Q

Source

Volume

26

Issue

Start Page

End Page

Endorsement

Review

Supplemented By

Referenced By